Beginning GLP-1 agonist treatment requires coordinated medical oversight, gradual dose escalation, and ongoing monitoring to balance benefits and tolerability. This guide outlines the essential preparation and execution steps for adults prescribed these medications for type 2 diabetes or chronic weight management.
How to Start GLP-1
Consultation with an endocrinologist or primary-care provider experienced in incretin therapy is the first requirement. The clinician reviews current medications, kidney and liver function, and history of pancreatitis or medullary thyroid carcinoma. Baseline labs typically include A1C, renal panel, and lipid profile. Patients receive counseling on expected gastrointestinal effects and the need for contraception if applicable. A prescription is issued only after contraindications are ruled out.
How to Start GLP-1 Agonist
Initiation follows a structured titration schedule supplied by the manufacturer. Most protocols begin at the lowest dose once weekly, injected subcutaneously in the abdomen, thigh, or upper arm on a consistent day. The first four weeks focus on acclimation rather than maximal efficacy. Patients are instructed to store pens refrigerated until first use, then at room temperature for up to 28 days. Injection technique is demonstrated during the office visit, and a sharps container is provided.
Why It Matters
Proper initiation reduces the incidence of nausea and vomiting that commonly lead to early discontinuation. Structured titration also allows clinicians to detect individual sensitivity early and adjust the schedule before side effects become severe. Consistent starting practices improve long-term adherence and therapeutic outcomes.
How to...
Follow these concrete steps once the prescription is filled:
- Confirm the dose and schedule with the prescribing clinician or pharmacist before the first injection.
- Choose an injection day that aligns with weekly routines to support adherence.
- Inject at the same time each week; if a dose is missed, resume on the next scheduled day unless more than five days have passed.
- Track symptoms and weight in a simple log to share at follow-up visits.
- Schedule the first lab review within four to eight weeks to assess tolerance and response.
Practical Monitoring Framework
- Week 1–4: lowest dose; focus on injection comfort and mild GI adaptation
- Week 5–8: first dose increase if tolerated; monitor for delayed gastric emptying
- Week 9–12: second increase or maintenance; reassess A1C or weight trajectory
- Ongoing: quarterly labs and annual eye exam if diabetic retinopathy is present
FAQ
What should I eat while starting a GLP-1 agonist?
Emphasize smaller, protein-forward meals spaced evenly throughout the day. Avoid high-fat or heavily spiced foods during the first weeks, as they can intensify nausea. Hydration between meals rather than with them often improves comfort.
How soon will I notice changes in appetite or blood sugar?
Most patients report reduced hunger within the first two weeks at the starting dose. Measurable improvements in fasting glucose typically appear by week four, with fuller effects seen after the first dose escalation.
Last updated: October 6, 2026